HIV in Correctional Settings
From CDC's Division of HIV/AID Prevention
HIV Testing Implementation Guidance for Correctional Settings
From CDC's Division of HIV/AIDS Prevention
Mass Incarceration, Housing Instability, and HIV/AIDS: Research Findings and...
HIV Among Older Americans
From CDC's Division of HIV/AIDS Prevention
Diagnoses of HIV Infection Among Adults Aged 50 Years and Older in the United States and Dependent Areas, 2007–2010
From CDC's Division of HIV/AIDS Prevention
We Are Members of This Community was formed to raise awareness of the issues that African American gay population face and to help end homophobia and the violence it spreads through hate. It is a resource for men who have sex with men (MSM) in the prevention and risk reduction of sexually...
This tool kit is a technical assistance guide that community-based organizations (CBOs) and similar organizations can use to support their HIV prevention services for transgender women of color (WOC).
Here are the CDC's answers to common questions about trichomoniasis. Find more questions and answers in Trichomoniasis—CDC Fact Sheet.
The fact sheet provides information on the similarities and differences between COVID-19 and TB.
![El COVID-19 y la Tuberculosis [COVID-19 and Tuberculosis]. Go to fact sheet.](/sites/default/files/styles/thumbnail/public/images/publications/el_covid-19_y_la_tb.png?itok=XuOwLWN_)
The fact sheet provides information on the similarities and differences between COVID-19 and TB.
In this video, viewers are taught what sputum is and the steps to collect a good sample for TB diagnostic purposes. The video can be shown prior to submitting sputum (e.g., spot samples, home visits, morning samples).
The CDC National Prevention Information Network (NPIN) is the U.S. reference and referral service for information on HIV/AIDS, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB). NPIN is a next-generation clearinghouse and collaborative community that collects and...
This material aims to inform national TB Programmes and other stakeholders about the key implications of the latest evidence on the use of specific molecular assays as initial diagnostic tests of pulmonary and extrapulmonary TB and RR-TB, in adults and children.